Efficacy and Safety of SIL-8301 for Control of Hemolysis in a Uniform Sickle Cell Disease Endotype

Clinical trial NCT07282210 · RECRUITING

Trial details

NCT number: NCT07282210
Sponsor: Biossil Inc.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Sickle Cell Disease Sickle Cell Anaemia Sickle Cell Anemia

Start date: 2026-08-13
Primary completion: 2029-01-01
Enrollment: 105

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.